| Serial Number | 99431659 |
| Word Mark | PROTEIMER |
| Filing Date | Tuesday, October 7, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, April 17, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Biopharmaceutical preparations for the treatment of cancer and neurological and neurodegenerative diseases; therapeutic proteins, namely, targeted binding proteins engineered for high-affinity and specificity to disease-associated targets, for use in modulating cellular signaling pathways and disease progression; biologic preparations for the treatment of oncological, neurological, metabolic, and immunological disorders; aptamer-based therapeutic agents for targeted treatment of cancer, including immune cell engagers that recruit and activate immune effector cells, including T cells and natural killer (NK) cells, against tumor cells, and for targeted delivery of therapeutic payloads, including cytotoxic agents, nucleic acids, and protein therapeutics, to specific human tissues; protein-based drug candidates, namely, multi-specific and modular biopharmaceutical preparations for the treatment of cancer and neurological and neurodegenerative diseases; antibody mimetics being engineered proteins for targeted modulation of disease pathways, selective receptor agonism or antagonism, blood-brain barrier penetration, and delivery of therapeutic agents to human tissue |
| Goods and Services | Scientific and technological research and design in the fields of biotechnology, pharmaceutical development, research and development of protein-based therapeutics, aptamer-based drug discovery platforms, biologic drug delivery systems, and biologically active molecules for therapeutic use; providing information in the field of scientific research and design in biotechnology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 7, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 7, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CrossLife Technologies Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Carlsbad, CA 92008 US |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Carlsbad, CA 92008 US |
| Event Date | Event Description |
| Tuesday, October 7, 2025 | NEW APPLICATION ENTERED |
| Tuesday, October 7, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, February 11, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 25, 2026 | ASSIGNED TO EXAMINER |
| Thursday, February 26, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, February 26, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, February 26, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 9, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 9, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 9, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 13, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, April 13, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 13, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, April 13, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Friday, April 17, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |